All In Biotech

Free tool

FAERS Monitor: Elitek

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103946 or its brand name (Elitek, Rasburicase). Reports on generic versions are filed under their own applications.

Reports

2,475

Serious

2,236

90% of reports

Hospitalization

1,323

Death reported

683

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • tumour lysis syndrome364
  • febrile neutropenia217
  • off label use216
  • acute kidney injury148
  • pyrexia147
  • drug ineffective140
  • neutropenia137
  • cytokine release syndrome133
  • sepsis104
  • multiple organ dysfunction syndrome103
  • anaemia96
  • respiratory failure95
  • hypotension90
  • pneumonia82
  • renal failure81

Reports by year received

View as table
YearReports
20047
20058
20065
200718
200812
200911
201027
201140
201254
201357
201463
201576
201696
2017139
2018243
2019155
2020195
2021251
2022222
2023199
2024229
2025190
2026178

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,684 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
tumour lysis syndromeSignal364366.7332.7126,969
cytokine release syndromeSignal13356.748.07,183
multiple organ dysfunction syndromeSignal10331.025.72,955
febrile neutropeniaSignal21727.924.65,598
respiratory failureSignal9511.19.1863
neutropeniaSignal1378.67.3914
acute kidney injurySignal1488.27.0938
sepsisSignal1047.96.6626
renal failureSignal815.24.2271
anaemiaSignal964.33.5240
hypotensionSignal903.83.1186
pyrexiaSignal1473.63.1279
pneumoniaSignal822.21.750
off label useSignal2162.11.8128
drug ineffective1400.90.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.